XML 43 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Shareholders' Equity - USD ($)
Common Stock [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Balances at Dec. 30, 2017 $ 29,501,123 $ (19,105,723) $ 97,921,903 $ (21,386,713) $ 86,930,590
Balances (in shares) at Dec. 30, 2017 8,957,974 (2,694,729)      
Net income     14,505,937   14,505,937
Cash dividends declared     (2,756,478)   (2,756,478)
Currency translation adjustment       (1,163,136) (1,163,136)
Change in fair value of interest rate swap       124,687 124,687
Change in pension and other postretirement benefit costs, net of tax       (203,353) (203,353)
Treasury stock purchases   $ (1,063,375)     (1,063,375)
Treasury stock purchases (in shares)   (40,000)      
Issuance of SARS $ 276,777       276,777
Issuance of SARS (in shares) 151        
Issuance of Common Stock for directors' fees $ 216,990       216,990
Issuance of Common Stock for directors' fees (in shares) 7,862        
Balances at Dec. 29, 2018 $ 29,994,890 $ (20,169,098) 109,671,362 (22,628,515) 96,868,639
Balances (in shares) at Dec. 29, 2018 8,965,987 (2,734,729)      
Net income     13,266,142   13,266,142
Cash dividends declared     (2,748,393)   (2,748,393)
Currency translation adjustment       68,377 68,377
Change in fair value of interest rate swap       574 574
Change in pension and other postretirement benefit costs, net of tax       (2,675,007) (2,675,007)
Issuance of SARS $ 397,250       397,250
Issuance of SARS (in shares) 151        
Issuance of Common Stock for directors' fees $ 259,675       259,675
Issuance of Common Stock for directors' fees (in shares) 9,296        
Balances at Dec. 28, 2019 $ 30,651,815 $ (20,169,098) $ 120,189,111 $ (25,234,571) $ 105,437,257
Balances (in shares) at Dec. 28, 2019 8,975,434 (2,734,729)